My research is focused on adoptive cellular therapy and allogeneic transplantation for hematological malignancies. After completing a fellowship in hematology and medical oncology in Japan, I joined the translational research program of the Nagoya University Graduate School of Medicine, where I trained for three years. My work involved the development of inducible chimeric antigen receptor (CAR) T cell therapy for acute lymphoblastic leukemia. An inducible model could reduce CART cell therapy-related toxicities such as off-target effects. I joined Dr. Kenderian’s laboratory at the Mayo Clinic in April 2017. I have led numerous innovative projects focused on developing CART cell therapies that target the microenvironment of hematological malignancies, non-invasively imaging CART cells with positron emission tomography and a combination of CART cell therapy with small molecule inhibitors.